Genetics
…CMT, including some patients with CMT2A. It can even happen in patients with CMT1X. (2) There are rare forms of X-linked CMT, defined as CMTX5 with mutations in the PRPS1…
The Winter 2021-2022 CMTA Report
…New CMT Podcast Dance 4 CMT Raises Funds Peaks Island Walk 4 CMT Country Music Star Reveals He Has CMT New Youth Council Members A Big Hike in Tiny Chunks…
CMTA_2017_Annual_Report
Breakthrough Guide to Orthopedic Surgery for CMT
…comprehensive approach to CMT foot surgery. Dr. Glenn Pfeffer and orthopedic surgeons met to define standards for the surgical treatment of foot deformities resulting from CMT. We are incredibly proud…
The Differences Between Charcot-Marie-Tooth Disease and Muscular Dystrophy (MD): An Overview
…No, CMT is not a form of MD. Although CMT shares many symptoms with the many forms of MD, CMT is a disease of the peripheral nerves and MD is…
CMTA-STAR Advisory Board Member Dr. D’Antonio Publishes in Brain, Identifies Potential Therapeutic Target for CMT1B
…therapeutic target not only for CMT1B but also for other demyelinating forms of CMT, including CMT1A and CMT1E. In CMT1B, mutations in the MPZ gene can cause Schwann cells, which…
Wilmington, NC CMTA Branch Meeting (In-Person) with Guest Speaker
05/04/2024 @ 10:00 am – 12:00 pm – Please join us for a CMT get-together on Saturday, May 4 from 10 am – 12 pm at the Northeast Library near Landfall Country Club (see library address below). This will be a fun get together combining a bit of education and a bit of social time. We will welcome special guest speaker, Kelsey Komyathy, […]
CMTA-STAR Awards $1.1 Million for CMT1X, CMT2A Clinical Trials
…March 23 aimed at helping top CMT scientists prepare for clinical trials for CMT1X and CMT2A. CMT is a degenerative neuromuscular disease that kills the long, or peripheral, nerves to…
Welcome to the Walk4CMT Toolbox
Welcome to the Walk4CMT Toolbox We are grateful that you have taken on a Walk 4 CMT event! This timeline will help you organize and promote your event, give you…
Gene Therapy for CMT1A, 1B, and X1: Progress in Nanoparticles
…the use of nanoparticles to deliver gene therapies directly to Schwann cells to treat CMTX1 (aka CMTX1, CMTX), the second most common type of CMT. This research focuses on using…